Stifel Nicolaus Starts Supernus Pharmaceuticals (SUPN) at Buy
Tweet Send to a FriendGet Alerts SUPN Hot Sheet
Price: $6.67 +0.30%
Rating Summary:
4 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 12 | New: 30
Rating Summary:
4 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 12 | New: 30
Trade SUPN Now!
Stifel Nicolaus initiates coverage on Supernus Pharmaceuticals (NASDAQ: SUPN) with a Buy. PT $15.00.
For an analyst ratings summary and ratings history on Supernus Pharmaceuticals click here. For more ratings news on Supernus Pharmaceuticals click here.
Shares of Supernus Pharmaceuticals closed at $5.94 yesterday, with a 52 week range of $5.16-$7.01.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For an analyst ratings summary and ratings history on Supernus Pharmaceuticals click here. For more ratings news on Supernus Pharmaceuticals click here.
Shares of Supernus Pharmaceuticals closed at $5.94 yesterday, with a 52 week range of $5.16-$7.01.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Canaccord Genuity Starts T-Mobile US, (TMUS) at Hold
- Oppenheimer Starts Neurocrine Bio. (NBIX) at Outperform
- Wells Fargo Starts StealthGas (GASS) at Outperform
Create E-mail Alert Related Categories
New CoverageRelated Entities
Stifel Nicolaus
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
